Federation of Clinical Immunology Societies

Interventional Immunology

	Interventional Immunology Boston Marriott Copley Place 110 Huntington Avenue Boston, Massachusetts, USA Thursday, June 24 at FOCIS 2010

Course Director Scott Plevy, MD University of North Carolina at Chapel Hill	Registration Opens: December 2, 2009 Registration Closes: May 26, 2010 Please note: Course sells out quickly! Register now. Interventional Immunology Registration Rate: $250 2 Course Package Rate including Interventional Immunology & Basic Immunology: $450

Target Audience/Purpose
The Interventional Immunology course is intended to familiarize practicing physicians with the scientific basis of novel immune therapies, their clinical applications, and possible side-effects and limitations.

Course Objectives
Upon completion of this activity, the participant should be able to:

Identify the scientific basis for choice of immunogically related therapeutic targets in various diseases, including organ specific and systemic autoimmunity, allergy, transplant rejection, cancer, and HIV.
Explain the rationale and mechanism underlying the major pharmacologic approaches for interventional immunology in current practice including, anti-cytokine therapy, costimulatory blockade, lymphocyte depletion, adhesion-molecule blockade, and signaling/lymphocyte activation blockade.
Evaluate the track record of the different therapeutic approaches in different specialties.
Recognize the cross-disciplinary lessons that can be learned from the clinical experience with specific interventions including pharmacological issues, limitations in altering disease progression and complications due to immunosuppression (infections, neoplasias).
Analyze how a physician should decide to use and choose therapies.

Preliminary Agenda

8:30 - 9:00 am	Check-in & Continental Breakfast
9:00 - 9:15 am	Welcome and Introductions Scott Plevy, MD, University of North Carolina at Chapel Hill
9:15 - 10:00 am	Immune Interventions in Psoriasis Alice B. Gottlieb, MD, Tufts University
10:00 - 10:45 am	Inflammasome Targeted Therapies Kenneth Rock, MD University of Massachusetts Medical School
10:45 - 11:00 am	Break
11:00 - 11:45 am	IL-17 and Pulmonary Inflammation Jay K. Kolls, MD, Louisiana State University
11:45 am - 12:30 pm	TNF Inhibitors: Mechanisms of Action Leonard H. Calabrese, DO, Cleveland Clinic Foundation
12:30 - 1:30 pm	Lunch
1:45 - 2:30 pm	Anti-Adhesion Therapies: Focus on MS Richard M. Ransohoff, MD, Cleveland Clinic Foundation
2:30 - 3:15 pm	Immune Therapy of Cancer Michael T. Lotze, MD
3:15 - 3:30 pm	Break
3:30 - 4:15 pm	Stem Cell Based Therapies for Inflammation Richard K. Burt, MD, Northwestern University
4:15 - 4:30 pm	Discussion, adjourn

Accreditation
The Federation of Clinical Immunology Societies is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education credits for physicians.

The Federation of Clinical Immunology Societies designates this educational activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

FOCIS Role in Human Immunology
Adrian Hayday, PhD